[Type 1 diabetes in children: Prevalence, morbidity and mortality in the Russian Federation]

L N Shcherbacheva1, T Y Shiryaeva1, Y I Suntsov1

  • 1Endocrinology Research Centre.

Problemy Endokrinologii
|October 20, 2019
PubMed

Insights

Epidemiological studies show a global rise in type 1 diabetes mellitus (T1DM) among children. In Russia, the State Register of SD (GDSD) monitors T1DM to improve pediatric diabetes care.

Area of Science:

  • Pediatric Endocrinology
  • Epidemiology
  • Public Health

Context:

  • Global incidence of type 1 diabetes mellitus (T1DM) in children is increasing.
  • The International Diabetes Federation (IDF) reports 430,000 children with diabetes worldwide, with a 3% annual growth.
  • Epidemiological studies in the Russian Federation are relatively recent, with the State Register of SD (GDSD) established in 1996.

Purpose:

  • To monitor key epidemiological indicators of T1DM in the pediatric population of the Russian Federation.
  • To assess the epidemic situation of T1DM across different regions of Russia.
  • To evaluate the quality of medical and preventive care for children with diabetes.

Summary:

  • The GDSD facilitates objective assessment of the T1DM epidemic in Russia, aiding in predicting incidence rates.
  • Analysis of T1DM incidence and prevalence in Russian children has been conducted since 2001 by the Institute of Pediatric Endocrinology.
  • Monitoring T1DM is crucial for organizing effective medical and preventive care and planning improvements for the pediatric diabetes service.

Impact:

  • Provides data for informed public health strategies and resource allocation in pediatric diabetes care.
  • Enables prediction of T1DM incidence, supporting proactive healthcare planning.
  • Contributes to improving the overall effectiveness of the children's diabetes service in the Russian Federation.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...